We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

118 hedge funds and large institutions have $374M invested in Spectrum Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $319M → $374M (+$55.6M)

13% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 39

3% less funds holding

Funds holding: 122118 (-4)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

34% less call options, than puts

Call options by funds: $2.72M | Put options by funds: $4.14M

Holders
118
Holders Change
-4
Holders Change %
-3.28%
% of All Funds
3.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
44
Reduced
39
Closed
15
Calls
$2.72M
Puts
$4.14M
Net Calls
-$1.43M
Net Calls Change
+$677K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.26M +$430K +53,087 +25%
BA
27
Bard Associates
Illinois
$2.16M +$1.62K +200 +0.1%
PP
28
PDT Partners
New York
$2.14M -$214K -26,457 -9%
BIM
29
BlackRock Investment Management
Delaware
$2.07M +$95.6K +11,805 +5%
CEI
30
Clark Estates Inc
New York
$1.93M
Ameriprise
31
Ameriprise
Minnesota
$1.72M +$81.6K +10,075 +5%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$1.61M +$178K +22,000 +13%
Macquarie Group
33
Macquarie Group
Australia
$1.57M -$57.6K -7,120 -4%
Thrivent Financial for Lutherans
34
Thrivent Financial for Lutherans
Minnesota
$1.55M -$1.21M -150,000 -45%
Charles Schwab
35
Charles Schwab
California
$1.25M +$133K +16,470 +12%
VOYA Investment Management
36
VOYA Investment Management
Georgia
$1.16M
Deutsche Bank
37
Deutsche Bank
Germany
$1.15M -$175K -21,629 -14%
Invesco
38
Invesco
Georgia
$1.12M -$14.6M -1,803,076 -93%
Public Sector Pension Investment Board (PSP Investments)
39
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.07M +$235K +29,000 +29%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$1.01M
Prudential Financial
41
Prudential Financial
New Jersey
$990K +$23.5K +2,900 +3%
SC
42
Sculptor Capital
New York
$969K
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$955K +$74.8K +9,238 +9%
CS
44
Credit Suisse
Switzerland
$936K -$725K -89,604 -45%
JP Morgan Chase
45
JP Morgan Chase
New York
$934K -$240K -29,647 -21%
Wells Fargo
46
Wells Fargo
California
$912K +$54.2K +6,695 +7%
AllianceBernstein
47
AllianceBernstein
Tennessee
$899K -$300 -37 -0%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$879K +$142K +17,588 +20%
PAMU
49
Pictet Asset Management (UK)
United Kingdom
$873K -$50.2K -6,200 -6%
BG
50
BlackRock Group
United Kingdom
$868K +$226K +27,862 +37%

SPPI Hedge Fund Activity: Q3 2013 in Review

118 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2013, worth a combined $374M — up 17% from $319M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SPPI and 12 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 44 added.

The largest buyer was Deerfield Management, adding an estimated $24.3M. The largest seller was Invesco, cutting an estimated $14.6M.

  • 118 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2013, down from 122 in Q2 2013.
  • Funds reported $374M of Spectrum Pharmaceuticals Inc stock for Q3 2013, up 17% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2013 and 15 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2013 was Deerfield Management, an estimated $24.3M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2013 was Invesco, an estimated $14.6M sold.

Based on aggregated 13F filings for Q3 2013.